Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-06-26
2007-06-26
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
10348510
ABSTRACT:
This invention provides estrogen receptor modulators of formula I, having the structurewherein,R1is hydrogen, alkyl of 1–6 carbon atoms, benzyl, alkylcarbonyl of 2–7 carbon atoms, or benzoyl;X isR2is hydrogen, alkyl of 1–6 carbon atoms, benzyl, alkylcarbonyl of 2–7 carbon atoms, or benzoyl;R3is hydrogen, alkyl of 1–6 carbon atoms, hydroxy, or alkoxy of 1–6 carbon atoms;a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable salt of a sulfate ester of the hydroxyl group at the 3- or 17-position when R1 or R2 is hydrogen, or a glucuronide of the hydroxyl group at the 3- or 17-position when R1 or R2 is hydrogen.
REFERENCES:
patent: 5633392 (1997-05-01), Berliner et al.
patent: WO 00/19994 (2000-04-01), None
patent: WO 00/31112 (2000-06-01), None
patent: WO 00/62765 (2000-10-01), None
patent: WO 01/68669 (2001-09-01), None
Albert Leo M.
Harris Heather A.
Keith, Jr. James C.
Megati Sreenivasulu
Miller Christopher P.
Hamilton Pepper
Hui San-Ming
Milowsky Arnold S.
Patané Michael A.
Wyeth
LandOfFree
6-Hydroxyequilenins as estrogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-Hydroxyequilenins as estrogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-Hydroxyequilenins as estrogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3823879